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ABSTRACT
Cervical cancer is a leading cause of death in women, worldwide, and second in Malaysia. Nowadays, modern cancer 
treatment comes with negative and adverse side effects to the patients. Traditional medicinal plants such as Clinacanthus 
nutans has been locally recognized for its medicinal properties and was claimed for cancer treatment. According to our 
pilot study, a fraction of C. nutans has shown a potent inhibition on human cervical cancer cells, SiHa, in vitro. Hence, 
this study aimed to investigate the underlying anticancer mechanism of a semi-purified fraction (SF1) of C. nutans towards 
cervical cancer cells. Bioassay guided fractionation and further purification was carried out. All collected fractions of 
C. nutans were examined for cytotoxicity activity towards HeLa, SiHa and NIH cells by MTT Assay. SF1 exhibited better 
cytotoxic activity with best growth inhibition against SiHa cells (IC50 value = 9.60 µg/mL). Cytoselective effects were 
shown as no cytotoxicity observed in the treated normal NIH cells. SF1 induced early apoptosis event in SiHa cells as 
resulted by FITC-Annexin V/propidium iodide staining by flowcytometric analysis. The protein expression by flowcytometry 
using specific antibody conjugated fluorescent dye showed up-regulation of Bax and down-regulation Bcl-2 as well as 
increment of cytochrome C levels upon treatment with SF1. In conclusion, the findings suggested that SF1 demonstrated 
antiproliferative effects and induced apoptosis in SiHa cells through up-regulation of Bax and down-regulation of Bcl-2 
via mitochondrial-dependent pathway. 
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ABSTRAK
Kanser pangkal rahim adalah penyebab utama kematian wanita di seluruh dunia dan kedua di Malaysia. Pada masa ini, 
rawatan moden kanser banyak memberi kesan negatif kepada pesakit. Tumbuhan ubatan  tradisi seperti Clinacanthus 
nutans telah dikenal pasti dan dipercayai oleh penduduk tempatan sebagai alternatif kepada rawatan kanser. Menurut 
kajian awal kami, satu fraksi daripada C. nutans telah menunjukkan perencatan yang aktif terhadap kanser serviks 
manusia, secara in vitro. Oleh itu, penyelidikan ini bertujuan untuk mengkaji mekanisme antikanser oleh fraksi separa - 
penulenan, SF1 daripada C. nutans terhadap kanser serviks. Penfraksian berpandukan bioaktiviti dan penulenan lanjutan 
telah dijalankan. Semua fraksi yang terkumpul daripada C. nutans telah diuji untuk aktiviti kesitoksikan terhadap sel 
HeLa, SiHa dan NIH oleh asai MTT. SF1 menunjukkan aktiviti sitotoksik yang lebih baik dengan antiproliferasi paling 
berpotensi terhadap sel SiHa (nilai IC50 = 9.60 μg/mL) dan menunjukkan kesan sitomemilih terhadap sel normal, NIH. 
Kesan apoptosis awal dapat diaruhkan terhadap sel SiHa daripada rawatan SF1 melalui analisis flositometri oleh 
pewarnaan FITC-Annexin V/propidium iodida. Pengekspresan protein menggunakan antibodi khusus berkonjugasi 
pendarfluor oleh analisis flositometri juga menunjukkan pengawalaturan Bax dan Bcl-2 serta peningkatan kadar sitokrom 
C setelah dirawat dengan SF1. Kesimpulannya, SF1 menunjukkan kesan antiproliferatif dan apoptosis yang diaruhkan 
dalam sel SiHa melalui pengawalaturan Bax dan Bcl-2.
Kata kunci: Apoptosis; Clinacanthus nutans; kanser serviks
INTRODUCTION
Cancer has been one of the major health threats in this 
world. In 2017, International Agency Research on Cancer 
(IARC), the specialized cancer agency of the World Health 
Organization (WHO) in its online database, GLOBOCAN, 
reported that more than 14 million new cancer cases 
and almost 10 million cancer-related deaths. GLOBOCAN 
also reported that cancer of the cervix uteri is the fourth 
most common cancer among women worldwide (Bruni 
et al. 2018). National Cancer Society of Malaysia 
(NCSM) reported that cervical cancer is the second most 
common cancer among women and the fourth leading 
cause of death in women aged between 15 and 44 years 
old, in Malaysia (Indramalar 2015). Among major factor 
contributing to cervical cancers is human papilloma virus 
(HPVs) such as HPV 16, 18 and 31. However, 70% of the 
1998 
cervical cancers comprises from HPV 16 and HPV 18 
(Choudari et al. 2013). 
 Among current treatment of cervical cancer are 
surgery and radiotherapy together with chemotherapy. 
Those treatment has remained first-line option to treat 
cervical cancer. However, the approach was limited by 
resistance, toxicity to surrounding healthy cells in body 
and expensive operation. Nowadays, many anticancer 
drugs have been developed by utilizing medicinal plants 
in both traditional and modern medicine (Ghasemzadeh 
et al. 2014). Usage of herbal medicine in cancer treatment 
has been used extensively by many Malaysian old folks 
to improve survivorship. Herbal medicine has been an 
asset to Malaysian due to richness of our herbal resources 
(Ch’ng et al. 2016). In developing countries such as 
Malaysia, 85% of people utilized traditional medicines 
derived from herbal plants for their primary health 
care (World Health Organization 2016). This positive 
trend could be due to insensitivity towards commercial 
anticancer drugs and existence of unwanted side effects of 
current cancer treatment. Therefore, new and safe drugs 
that originated from herbal plants are necessary in order 
to improve standard treatments, in vitro and in vivo. 
 Clinacanthus nutans or commonly known as Sabah 
Snake Grass or Belalai Gajah, is a medicinal plant native 
to the tropical Asia countries including China, Vietnam, 
Thailand, Malaysia and Indonesia (Huang et al. 2016; Le 
et al. 2017). C. nutans belongs to family Acanthaceae. This 
type of plant grows easily in nearly every habitat such as 
open or dense forests in tropical areas. Traditionally, this 
plant has been used by local to treat dysentery, fever, viral 
infection, skin rashes and insect bites (Ghasemzadeh et al. 
2014; Sulaiman et al. 2015). In Malaysia, the fresh leaves 
of C. nutans are consumed as a juice or herbal tea upon 
boiled with water (Alam et al. 2016). A few numbers of 
studies related to antiproliferative properties of C. nutans 
have been extensively described. Chloroform extract 
has been reported capable of scavenging free radical 
and inhibited the growth of cervical cancer, HeLa cells 
(Yong et al. 2013). Ethanol extract from the aerial part 
was reported could inhibit hepatoma in mice, indicated 
the potential antitumor and immunomodulatory properties 
of C. nutans (Huang et al. 2015). Same research group 
also attempted purification of a polysaccharide peptide 
complex from the C. nutans leaves, showed potential 
for gastric cells inhibition (Huang et al. 2016). Despite 
numerous identified studies related to antiproliferative 
activity of this plant, little information regarding its 
anticancer mechanism was reported. From our pilot 
study, a fraction of C. nutans named as F11 was found to 
be active towards human cervical carcinoma cell, HeLa 
and arrest cell cycle at G1/S phase (Roslan et al. 2018). 
Hence, the aim of the present study was to determine 
the cytotoxic effects and mechanism of cell death of a 
semi-purified fraction of C. nutans against human cervical 
carcinoma, in vitro.
MATERIALS AND METHODS
COLLECTION AND AUTHENTICATION OF C. NUTANS
The fresh parts including stem with leaves, shoots and 
branches of C. nutans (Burm.f.) Lindau were freshly 
collected from Pengkalan Chepa, Kelantan. The specimen 
was authenticated by botanist, Dr Shamsul Khamis, 
Herbarium Kulliyyah of Pharmacy, Universiti Islam 
Antarabangsa Malaysia (UIA). A voucher specimen of the 
C. nutans (No. PIIUM 0238-2) was prepared and deposited 
at the herbarium. The leaves were washed and dried in 
drying oven at 50oC for overnight. The dried leaves of C. 
nutans were ground to coarse powder using laboratory 
grinder. 
EXTRACTION, ISOLATION AND PURIFICATION OF C. nutans
The dried powdered leaves were sequentially extracted 
with hexane and chloroform, respectively (Sakdarat et al. 
2009). The extract was concentrated in vacuo at 40oC to 
yield dried chloroform extract. For isolation of C. nutans, 
the chloroform extract was initially chromatographed on a 
silica gel 60 (250 g) using column with dry vacuum liquid 
chromatographic technique. The column was eluted with 
hexane - ethyl acetate (1:1) in order to collect and isolate 
only the active fraction named as F11 (Roslan et al. 2018). 
The fractions were collected by monitoring with thin-layer 
chromatography (TLC), chloroform - methanol (1:1). In 
order to further characterize the F11, purification of F11 
were carried out by chromatographed on silica gel 60 (200 
g) using dry vacuum liquid chromatographic technique. 
Approximately 2 g of F11 was loaded onto the column. 
The column was eluted with acetonitrile - methanol (2:8). 
A portion of each fraction was separated by preparative 
TLC chloroform - methanol (2:8) and retention factor (Rf) 
for each TLC plates were calculated as (distance moved by 
solute)/(distance moved by solvent).
CYTOTOXICITY STUDIES
In order to determine the potent cell inhibition property, all 
collected fractions were examined for cytotoxicity activity 
towards two types of human cervix carcinoma cell lines 
(HeLa cells and SiHa cells) and normal fibroblast cell 
line (NIH cells) by MTT Assay. HeLa cells and NIH cells 
were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) while SiHa cells was maintained in Roselle’s Park 
Memorial Institute (RPMI) 1640 medium. Both medium 
was supplemented with 5% fetal bovine serum and 1% 
penicillin-streptomycin. The cell lines were maintained at 
37oC in a humidified 5% CO2 incubator. Briefly, 90% of 
confluent cells were seeded overnight prior to treatment 
in 96 well plates at 5×104 cells/well. The F1, F2, F3 and 
F4 were dissolved in DMSO and followed by a serial 
dilution ranged from 0.2 μg/mL to 100 μg/mL. Cisplatin 
was used as a positive control and DMSO acted as negative 
control. The plates were incubated for 72 h at 37oC in a 
humidified 5% CO2. At the end of incubation, old medium 
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was discarded and 50 μL of MTT solution was added to each 
well. The plates were then incubated for another 4 h. Later, 
MTT solution was removed and purple formazan formed 
at the bottom of plates were dissolved with 200 μL DMSO. 
The plates were then shaken for 30 min and the absorbance 
at 570 nm was read on spectrophotometric microplate 
reader. The percentage of cell viability was calculated as 
(optical density treated)/(optical density negative control) 
×100%. Dose response curves were constructed to obtain 
IC
50 
values. 
PERCENTAGE OF APOPTOSIS EVENT
The cells were seeded in 25 cm2 flasks under a humidified 
5% CO2 atmosphere at 37
oC for overnight. The cells 
concentration for each flask was 5×104 cells/mL. The 
next day, the cells were treated with IC
50
 of SF1 and IC
50
 
of cisplatin for 24, 48 and 72 h. The untreated cells were 
used as negative control. After each of incubation period, 
the SF1-treated, the cisplatin-treated and untreated cells 
were harvested and collected after centrifuged. The cell 
pellet was gently rinsed with medium. The tubes were 
spin at 2000 rpm for 5 min. The cell pellet was washed 
with cold PBS. The tubes were further centrifuged at 2000 
rpm for 5 min and re-suspend in 1 X Binding Buffer at 
a concentration of total cells of 1×106 cells/mL. The cell 
suspension of 100 μL with 1×105 cell/mL was transfer to 
flowcytometry tube. Five μL of Annexin V FITC and 5 μL of 
propidium iodide were added to the cell suspension. Each 
tube was gently vortex and incubated at room temperature 
in the dark room for 15 min. 1 X Binding Buffer of 400 μL 
was added and samples were analysed immediately within 
1 h. In this assay, three types of control were prepared for 
compensation of flowcytometry; SiHa cell suspension and 
propidium iodide; SiHa cell suspension and Annexin V 
FITC and only SiHa cell suspension.
DETECTION OF APOPTOTIC PROTEIN EXPRESSION
The cells were seeded in 25 cm2 flasks under a humidified 
5% CO2 atmosphere at 37
oC for overnight. The cells 
concentration for each flask was 5×104 cells/mL. The 
next day, the cells were treated with IC
50
 of SF1 and IC
50
 
of cisplatin for 24, 48 and 72 h. The untreated cells were 
used as negative control. After each of incubation period, 
the SF1-treated, the cisplatin-treated and untreated cells 
were collected after centrifuged. Cells were fixed in ice 
cold 70% ethanol. The tubes were gently vortexed for 1 
h at 20oC. Then, the cell pellet was washed twice with 1 
X PBS and re-suspended in blocking buffer that consist 
of 2% bovine serum albumin (BSA) for 10 min. Then, 
another washing step was carried out. Cell pellet was re-
suspended in PBS to a concentration of 1×107 cells/mL. 
Then, 100 μL of cells suspension with concentration of 
1×106 cells/mL was transferred into flowcytometry tubes. 
20 μL of PE conjugated antibody was added into tubes. 
The Bax-PE conjugated antibody, Bcl-2-FITC conjugated 
and cytochrome C-PE conjugated were used in this study. 
Later, the tubes were maintained for 30 min in the dark at 
room temperature. The pellets were washed with 1 mL of 
1 X PBS. The cell pellets were re-suspended in 500 μL of 
1 X PBS and ready to proceed for flowcytometry analysis. 
STATISTICAL ANALYSIS
Statistical analysis was performed using Graph Pad PRISM 
Version 6.0 GraphPad Software Inc, California, United 
States. Each experiment was conducted in triplicate and 
expressed as mean ± S.D. Statistical significances of data 
obtained were calculated and determined using Students’ 
paired t-test or two-way ANOVA with Turkey’s multiple 
comparison tests.
RESULTS AND DISCUSSION
EXTRACTION, ISOLATION AND PURIFICATION
All collected fractions with similar TLC profile were 
combined to afford total of four fractions known as F1, 
F2, F3 and F4. F1 was obtained as yellowish - green paste 
while F2 and F3 was in darker green. F4 was obtained in 
slightly lighter in green colour compared to F2 and F3. 
The Rf value for each collected fraction were tabulated 
in Table 1.
TABLE 1. Rf values for each fraction 
Fraction Rf value
F1
F2
F3
F4
0.81
0.78
0.77
0.78
CYTOTOXIC ACTIVITY OF SEMI-PURIFIED                     
FRACTION OF C. nutans
Cytotoxicity is the ability of plants derived compound to 
arrest the proliferation of cells (Zakaria et al. 2017). In this 
present study, MTT assay was utilized as cytotoxicity test 
in order to obtain IC
50 
values. IC
50 
value can be defined as 
half maximal inhibitory concentration in a population (Ng 
et al. 2017). United States National Cancer Institute (NCI) 
plant screening program reported that IC
50 
value less than 
20 μg/mL for extract or fraction, and less than 4 μg/mL 
for pure compound can be generally considered having 
cytotoxic properties, in vitro (Boik 2001). This indicator 
was used as reference value throughout this current study. 
The lowest IC
50 
values from all collected fractions against 
HeLa, SiHa and NIH were shown in Table 2. Figure 1(A), 
1(B) and 1(C) shows dose response curves of all collected 
fractions towards HeLa, SiHa and NIH cells, respectively. 
 There was no remarkable IC50 values were detected 
on NIH cell proliferation as the IC50 values for all fractions 
were more than the highest concentration used in this 
experiment. Zazali et al. (2013) reported that when the IC50 
values are more than 99 µg/mL on proliferation of normal 
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cells, no inhibition effects are shown. Similar findings also 
showed that ethyl acetate and methanol roots extract of C. 
nutans showed little inhibition on NIH normal cells which 
indicated that no harmful effect was detected (Teoh et al. 
2016). The positive control, cisplatin, one of commonly use 
chemotherapy drug for cervical cancers (Zhen et al. 2016) 
exhibited strong cytotoxic activity on all tested cell line; 
2.76 ± 1.06 µg/mL on NIH cells, 2.95 ± 1.20 µg/mL on HeLa 
and 2.29 ± 1.16 µg/mL on SiHa cells. The main purpose of 
any anticancer chemotherapy drug is to specifically target 
on cancer cells without or with minimal effect on normal 
cells (Jaudan et al. 2018). However, cisplatin failed to 
achieve this aim due to its action are general, unspecified 
and cause severe side effects (Huang et al. 2016; Zhen et 
al. 2016). 
 Within the four fractions, F3 inhibited growth of HeLa 
cells with IC50 values 14.16 ± 1.28 µg/mL while F2, F3 and 
F4 showed potent inhibition towards SiHa cells with IC50 
values 9.81 ± 1.15 µg/mL, 11.68 ± 1.27 µg/mL and 7.33 
± 1.23 µg/mL, respectively. Other studies reported that C. 
nutans hexane extracts showed IC50 values of 74 µg/mL on 
lung cancer, A549 and 25 µg/mL on HepG2, liver cancer 
(Ng et al. 2017). To compare with other related studies, 
the growth of HeLa cells was inhibited when treated 
with chloroform extract and active fraction of C. nutans, 
respectively (Roslan et al. 2018; Yong et al. 2013). The 
aqueous extract of C. nutans also has showed a cytotoxic 
effect towards HeLa cell with IC50 value of 13 ± 0.82 μg/
mL without affecting normal cell, Vero (Zakaria et al. 
2017). However, in the present findings, most fractions of 
C. nutans showed better inhibition and highly sensitive 
towards SiHa cells compared to HeLa cells, as lower 
IC50 values were exhibited. The SiHa cells showed most 
effective inhibition (lowest IC50 values) when treated with 
the fractions of C. nutans. Therefore, SiHa cells are more 
susceptible to C. nutans treatment compared to HeLa 
cells. SiHa cells are cervical squamous carcinoma cell 
that contains integrated HPV 16 genotype whereas HeLa 
cells are cervical adenocarcinoma that integrated HPV 
18 genotype (Choudari et al. 2013; He et al. 2017). This 
current study demonstrated potent cytotoxic properties of 
C. nutans towards SiHa cells. Thus, SiHa cells was selected 
for further experiments. 
 Based on the IC
50
 values obtained, F2, F3 and F4 
showed highly inhibition on SiHa cells as compared to F1. 
Beside IC
50
 values, these three fractions displayed similar 
Rf values. Therefore, F2, F3 and F4 were combined and 
named as SF1. SF1 was subjected for further experiments 
for determination of mechanism of cell death. Hence, the 
average IC
50 
values of F2, F3 and F4 which is 9.60 μg/mL 
was used in the subsequent experiments. 
INDUCTION OF APOPTOTIC CELL DEATH OF SF1
Mode of apoptotic cell death on SF1-treated SiHa cells 
was investigated through double staining with Annexin V 
and propidium iodide (PI). This was carried out in order 
to determine the mechanism of cell death of SF1 from C. 
nutans against SiHa cells. Figure 2 shows that staining with 
Annexin V and PI allowed differentiation and quantification 
FIGURE 1. Dose response curve of F1, F2, F3, F4 and cisplatin towards (A) HeLa cells, (B) SiHa cells and (C) NIH cells
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of four cell types in four quadrant analysis; Q1 (PI positive, 
Annexin V negative), Q2 (PI positive, Annexin V positive), 
Q3 (PI negative, Annexin V negative) and Q4 (PI negative, 
Annexin V positive). Phosphatidylserine (PS) from inner 
side of plasma membrane was translocated to outer cell 
surface thus allow Annexin V binds to the PS during early 
apoptosis event (Jaudan et al. 2018; Zazali et al. 2013). 
Subsequently, PI stained DNA of a damaged cell membrane 
during late apoptosis. Following treatment with IC
50
 values 
of SF1 towards SiHa cells, the percentage of early apoptotic 
cells (Q4) were significantly increased (p<0.0001) from 
20.27 ± 2.15%, 47.03 ± 4.56% until 67.70 ± 2.36% 
throughout 24, 48 and 72 h, compared to untreated control 
group (Figure 3(A) and 3(B)). These findings showed that 
SF1 was able to induce apoptosis in SiHa cells in a time-
dependent manner. 
 The present findings also showed that upon treatment 
with lower IC
50 
value towards SiHa cells, SF1 managed 
to induce apoptosis compared to higher concentration 
used by other researchers. As example, Ng et al. (2017) 
demonstrated that C. nutans hexane extract (150 μg/mL) 
induced apoptosis in CNE1 and HepG2 cells. Meanwhile, 
Fong et al. (2016) reported that late apoptosis occurred 
in D24 melanoma cells treated with 2 mg/mL methanol 
TABLE 2. The IC
50 
values of C. nutans fractions against HeLa, SiHa, NIH cells. The values are represented 
as mean±S.D with *p<0.05 was taken as significantly different from cisplatin
Cell lines IC50 values (μg/mL)
F1 F2 F3 F4 Cisplatin
HeLa
SiHa
NIH
>100
40.22±1.15*
>100
>100
9.81±1.15*
>100
14.16±1.28*
11.68±1.27*
>100
75.66±1.15*
7.33±1.23*
80.92 ± 1.29*
2.95±1.20
2.29±1.16
2.76±1.06
Duration of 
treatment
24 h 48 h 72 h
SF1
CP
UT
FIGURE 2. Scatter plots of SiHa cells stained with PI/FITC - Annexin V in quadrant analysis; viable cells (Q3), early 
apoptotic cells (Q4), late apoptotic cells (Q2) and necrotic cells (Q1) in untreated SiHa cells (UT), SF1-treated SiHa cells 
(SF1) and cisplatin-treated SiHa cells (CP) for 24, 48 and 72 h
2002 
extract of C. nutans, hence increased the percentage of late 
apoptosis and decrease in viable cells at longest treatment 
time, 72 h. In contrast with positive control drug, cisplatin 
(Figure 3(C)), the percentage of early apoptosis was 60.20 
± 2.17% after only 24 h of treatment. However, at 72 h 
treatment period, the number of early apoptotic cells were 
decreased to 4.53 ± 0.83%. The major population of SiHa 
cells-treated cisplatin were detected at late apoptosis (Q2) 
with 88.07 ± 5.35%. This was in accordance with Santin et 
al. (2011) that reported as early as 48 h of treatment with 
cisplatin in neuroblastoma cell, there are more than 50% of 
late apoptotic cells were shown. In untreated SiHa cells, the 
number of viable cells (Q3) were remained high throughout 
treatment period indicating that cells continuously growth 
and apoptosis occur as a typical process in cells (He et 
al. 2017; Zazali et al. 2013). Taken together, SF1 has a 
capability to trigger early apoptosis event in SiHa cells 
within 72 h treatment period.
DETECTION OF APOPTOTIC PROTEIN                          
EXPRESSION INDUCED BY SF1
The mechanism of apoptosis pathway in SF1-treated SiHa 
cells was further examined through determination of Bax, 
Bcl-2 and cytochrome C proteins. The apoptosis pathway 
can occur via extrinsic or intrinsic pathway (Teoh et al. 
2016). In this study, the main focused was on intrinsic 
pathway where activation of this pathway is regulated 
by Bcl-2 family proteins such as Bax, pro-apoptotic 
proteins and Bcl-2, anti-apoptotic proteins (Huang et 
al. 2015; Zazali et al. 2013). Results indicated that the 
level of Bax (Figure 4(A)) was increased dramatically as 
prolonged incubation time with SF1. The Bax levels of 
40.90 ± 2.89%, 61.17 ± 0.80% and 74.97 ± 5.69% were 
observed throughout 24 h, 48 h and 72 h, respectively. 
On the contrary from untreated cells, the percentage of 
Bax were remain low at all treatment hours. The levels 
of Bcl-2 (Figure 4(B)) were 63.30 ± 0.60% at 24 h and 
significantly decreased to 56.47 ± 1.27% at 48 h followed 
by major decrement to 22.33 ± 3.43% at 72 h treatment 
with SF1 (p<0.001). As compared to untreated cells, the 
percentage of Bcl-2 were remained higher where more 
than 90% population were observed during all incubation 
time. Throughout 24 h until 72 h of SF1 treatment, the 
expression of cytochrome C (Figure 4(C)) increased 
gradually from 18.87 ± 4.16%, 47.17 ± 5.85% and 81.80 ± 
3.25%, respectively. No significant increment can be seen 
of cytochrome C levels in untreated cells. The cisplatin-
FIGURE 3. Percentage of cell count in each quadrant for (A) untreated SiHa cells, (B) SF1-treated SiHa cells and (C) 
cisplatin-treated SiHa cells. Each point represented mean±S.D of three independent experiments with ****p<0.0001, 
***p<0.001, **p<0.01 and *p<0.05 were taken as significantly different with treatment duration
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Duration of 
treatment
24 h 48 h 72 h
SF1
CP
UT
Duration of 
treatment
24 h 48 h 72 h
SF1
CP
UT
continue
2004 
Duration of 
treatment
24 h 48 h 72 h
SF1
CP
UT
FIGURE 4. Histogram profile of (A) Bax, (B) Bcl-2 and (C) Cytochrome C proteins expression detected by flowcytometry analysis 
in untreated SiHa cells (UT), SF1-treated SiHa cells (SF1) and cisplatin-treated SiHa cells (CP) for 24 h, 48 h and 72 h
A
C
FIGURE 5. Expression levels of Bcl-2, Bax and cytochrome C for (A) untreated SiHa cells, (B) SF1-treated SiHa cells and (C) 
cisplatin-treated SiHa cells. The value of bars represented mean ± SD of three independent experiment with ****p<0.0001, 
***p<0.001 and **p<0.01 were taken as significant different with the treatment durations
B
  2005
treated SiHa cells showed typical increment in expression 
of Bax and cytochrome C and decrement of Bcl-2 levels 
throughout all treatment duration (Figure 5(C)). 
 The present findings are synchronized with previous 
studies where Western blot analysis of 30% ethanol extract 
from C. nutans induced apoptosis in hepatoma cells with 
increased expression levels of Bax and decreased in Bcl-
2 expression (Huang et al. 2015). Real-Time Polymerase 
Chain Reaction (RT-PCR) analysis also showed that ethyl 
acetate and methanol roots extracts of C. nutans promote 
apoptosis by suppressing the expression of anti-apoptotic 
gene, Bcl-2 while maintaining the expression of pro-
apoptotic gene, Bax in MCF-7 cells (Teoh et al. 2016). 
The higher production of Bax in SF1-treated SiHa cells 
might be activated by p53 thus, stimulating the release of 
cytochrome C from mitochondria to cytosol (Chipuk & 
Green 2008; Zazali et al. 2013). There are several previous 
studies demonstrated that apoptosis was induced directly by 
up-regulation of Bax, down-regulation of Bcl-2 and release 
of cytochrome C via mitochondrial pathway in human 
cervical cancer cells (Huang et al. 2015; JuÈrgensmeier et 
al. 1998; Xu et al. 2017). Hence, the apoptosis induction 
in SF1-treated SiHa cells was promoted by action of Bax 
thus activated the mitochondrial-dependent pathway of 
apoptosis. 
CONCLUSION
SF1 selectively inhibited the growth of SiHa cells without 
affecting normal cells. The inhibitory effect of SF1 towards 
SiHa cells was associated with induction of apoptosis cell 
death via mitochondrial pathway. Further in vivo studies 
and identification of responsible anticancer compound 
will be carried out. Nevertheless, these current findings 
provide a platform to further explore the mechanism of 
action of SF1. 
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